Zhengtao Chu

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Xiaoyang Qi · 5 shared papers, 2013–2020 · strength 0.30
   • Paper Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer. DOI 10.1016/j.ymthe.2020.05.013↗
   • Paper Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles. DOI 10.1016/j.tranon.2015.03.011↗
   • Paper Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread… DOI 10.18632/oncotarget.7955↗
2. Syed Ameen Ahmad · 4 shared papers, 2013–2020 · strength 0.23
   • Paper Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer. DOI 10.1016/j.ymthe.2020.05.013↗
   • Paper Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread… DOI 10.18632/oncotarget.7955↗
   • Paper Targeting and cytotoxicity of SapC-DOPS nanovesicles in pancreatic cancer. DOI 10.1371/journal.pone.0075507↗
3. Vladimir Y. Bogdanov · 3 shared papers, 2014–2020 · strength 0.19
   • Paper Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer. DOI 10.1016/j.ymthe.2020.05.013↗
   • Paper Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread… DOI 10.18632/oncotarget.7955↗
   • Paper Alternatively spliced tissue factor contributes to tumor spread and activation of coagulation in pancreatic ductal aden… DOI 10.1002/ijc.28327↗
4. Clayton S. Lewis · 2 shared papers, 2016–2020 · strength 0.15
   • Paper Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer. DOI 10.1016/j.ymthe.2020.05.013↗
   • Paper Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread… DOI 10.18632/oncotarget.7955↗
5. Kombo F. N’Guessan · 1 shared paper, 2020 · strength 0.11
   • Paper Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer. DOI 10.1016/j.ymthe.2020.05.013↗
6. Harold W. Davis · 1 shared paper, 2020 · strength 0.11
   • Paper Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer. DOI 10.1016/j.ymthe.2020.05.013↗
7. Jen Jen Yeh · 1 shared paper, 2020 · strength 0.11
   • Paper Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer. DOI 10.1016/j.ymthe.2020.05.013↗
8. Olugbenga Olanrele Olowokure · 1 shared paper, 2020 · strength 0.11
   • Paper Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer. DOI 10.1016/j.ymthe.2020.05.013↗
9. Dusten J. Unruh · 2 shared papers, 2014–2016 · strength 0.08
   • Paper Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread… DOI 10.18632/oncotarget.7955↗
   • Paper Alternatively spliced tissue factor contributes to tumor spread and activation of coagulation in pancreatic ductal aden… DOI 10.1002/ijc.28327↗
10. Victor Blanco · 1 shared paper, 2015 · strength 0.07
    • Paper Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles. DOI 10.1016/j.tranon.2015.03.011↗
11. Nigel Mackman · 1 shared paper, 2016 · strength 0.05
    • Paper Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread… DOI 10.18632/oncotarget.7955↗
12. Alisa S. Wolberg · 1 shared paper, 2016 · strength 0.05
    • Paper Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread… DOI 10.18632/oncotarget.7955↗
13. Georg F. Weber · 1 shared paper, 2016 · strength 0.05
    • Paper Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread… DOI 10.18632/oncotarget.7955↗
14. Holger Kalthoff · 1 shared paper, 2014 · strength 0.03
    • Paper Alternatively spliced tissue factor contributes to tumor spread and activation of coagulation in pancreatic ductal aden… DOI 10.1002/ijc.28327↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.